Same Indication

Midazolam vs Yttrium Y 90 Ibritumomab Tiuxetan

Midazolam vs Yttrium Y 90 Ibritumomab Tiuxetan: Overview

This comparison examines the pharmacological differences between Midazolam and Yttrium Y 90 Ibritumomab Tiuxetan.

Mechanism of Action

Midazolam: Ultra-short-acting benzodiazepine GABA-A receptor positive allosteric modulator.

Pharmacokinetics

Half-life: Midazolam β€” 1.5-2.5 hours.

Chemical Properties

Molecular Formula: Midazolam β€” C18H13ClFN3.

Molecular Weight: Midazolam β€” 325.7670 g/mol.

Type: Midazolam β€” Small molecule; Yttrium Y 90 Ibritumomab Tiuxetan β€” Antibody.